Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Olink Holding Ab [Publ] ADR (NQ: OLK )

25.54 +0.03 (+0.12%)
Streaming Delayed Price Updated: 1:24 PM EDT, Jun 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Olink Holding Ab [Publ] ADR

< Previous 1 2 Next >
Olink publishes 2022 annual report
From Olink Proteomics AB
Via GlobeNewswire
Bruno Rossi joins Olink as Chief Commercial Officer
From Olink Proteomics AB
Via GlobeNewswire
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
From Olink Proteomics AB
Via GlobeNewswire
NUS Medicine implements Olink technology to accelerate precision medicine through next-generation proteomics
From Olink Proteomics AB
Via GlobeNewswire
Olink establishes agreement with Regeneron Genetics Center to scale their proteomics efforts, potentially enabling a new era of drug discovery
From Olink Proteomics AB
Via GlobeNewswire
Olink reports fourth quarter and full year 2022 financial results
From Olink Proteomics AB
Via GlobeNewswire
Olink Holding AB (publ) announces pricing of public offering of American Depositary Shares
From Olink Proteomics AB
Via GlobeNewswire
Olink Holding AB (publ) launches public offering of American Depositary Shares
From Olink Proteomics AB
Via GlobeNewswire
Olink announces preliminary unaudited revenue for the fourth quarter and full year 2022 and provides outlook for 2023
From Olink Proteomics AB
Via GlobeNewswire
Olink to participate in the 41st Annual JP Morgan Healthcare Conference
From Olink Proteomics AB
Via GlobeNewswire
Maria Martin-Grau, at the University of Valencia, Spain is selected for the 2022 Novelties in Biomarkers award
From Olink Proteomics AB
Via GlobeNewswire
Announcing Olink® Flex, a new, unique and fully flexible low-plex proteomics solution using absolute quantification
From Olink Proteomics AB
Via GlobeNewswire
Olink reports third quarter 2022 financial results
From Olink Proteomics AB
Via GlobeNewswire
Olink announces milestone achievement of 1,000 peer-reviewed articles citing use of PEA technology
From Olink Proteomics AB
Via GlobeNewswire
Olink to participate in November investor events
From Olink Proteomics AB
Via GlobeNewswire
Announcing Olink® Insight, a digital knowledge-sharing platform to amplify the value of proteomics data
From Olink Proteomics AB
Via GlobeNewswire
Olink to report third quarter 2022 financial results on November 10, 2022
From Olink Proteomics AB
Via GlobeNewswire
Psomagen, Inc. Is Partnering with Olink Proteomics, Enabling Unprecedented Multi-Omics Clinical Studies
From Psomagen, Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.